Int J Biol Sci 2014; 10(2):181-191. doi:10.7150/ijbs.6232 This issue Cite

Research Paper

Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease

Lan Zhang, Cong Shen, Jin Chu, Ruyi Zhang, Yali Li, Lin Li✉

Department of Pharmacology, Xuanwu Hospital of Capital Medical University, Key Laboratory for Neurodegenerative Diseases of Ministry of Education, Beijing 100053, China.

Citation:
Zhang L, Shen C, Chu J, Zhang R, Li Y, Li L. Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease. Int J Biol Sci 2014; 10(2):181-191. doi:10.7150/ijbs.6232. https://www.ijbs.com/v10p0181.htm
Other styles

File import instruction

Abstract

Objective: The purpose of this study was to investigate the effects and pharmacological mechanisms of icariin, which is the main component in the traditional Chinese herb Epimedium, on β-amyloid (Aβ) production in an amyloid precursor protein (APP) transgenic (Tg) mouse model of Alzheimer's disease (AD).

Methods: APPV717I Tg mice were randomly divided into a model group and icariin-treated (30 and 100 μmol/kg per day) groups. Learning-memory abilities were determined by Morris water maze and object recognition tests. Aβ contents were measured by enzyme-linked immunosorbent assays and immunohistochemistry. Amyloid plaques were detected by Congo red staining and Bielschowsky silver staining. The levels of expression of APP and β-site APP-cleaving enzyme 1 (BACE-1) were measured by western blotting and immunohistochemistry.

Results: Ten-month-old Tg mice showed obvious learning-memory impairments, and significant increases in Aβ contents, amyloid plaques, and APP and BACE-1 levels in the hippocampus. The intragastric administration of icariin to Tg mice for 6 months (from 4 to 10 months of age) improved the learning-memory abilities and significantly decreased the Aβ contents, amyloid plaques, and APP and BACE-1 levels in the hippocampus.

Conclusion: Icariin reduced the Aβ burden and amyloid plaque deposition in the hippocampus of APP transgenic mice by decreasing the APP and BACE-1 levels. These novel findings suggest that icariin may be a promising treatment in patients with AD.

Keywords: Icariin, Alzheimer's disease, APPV717I transgenic mice, β-amyloid, amyloid plaque, BACE-1, amyloid precursor protein


Citation styles

APA
Zhang, L., Shen, C., Chu, J., Zhang, R., Li, Y., Li, L. (2014). Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease. International Journal of Biological Sciences, 10(2), 181-191. https://doi.org/10.7150/ijbs.6232.

ACS
Zhang, L.; Shen, C.; Chu, J.; Zhang, R.; Li, Y.; Li, L. Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease. Int. J. Biol. Sci. 2014, 10 (2), 181-191. DOI: 10.7150/ijbs.6232.

NLM
Zhang L, Shen C, Chu J, Zhang R, Li Y, Li L. Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease. Int J Biol Sci 2014; 10(2):181-191. doi:10.7150/ijbs.6232. https://www.ijbs.com/v10p0181.htm

CSE
Zhang L, Shen C, Chu J, Zhang R, Li Y, Li L. 2014. Icariin Decreases the Expression of APP and BACE-1 and Reduces the β-amyloid Burden in an APP Transgenic Mouse Model of Alzheimer's Disease. Int J Biol Sci. 10(2):181-191.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image